News and Updates - Breakthrough T1D

Press releases

Read the latest press releases and statements from Breakthrough T1D.

November 22, 2024

Breakthrough T1D, Formerly JDRF, Statement on FDA Decision Not to Approve Zynquista (sotagliflozin) for Glucose Control in People with Type 1 Diabetes and Chronic Kidney Disease

November 18, 2024

Breakthrough T1D Applauds Senate Diabetes Caucus Co-Chairs for Leading Bipartisan Letter of Support for Special Diabetes Program

November 15, 2024

Breakthrough T1D Leads Effort to Make Screening for T1D Part of Recommended Preventive Services in the US

Get the latest in T1D news updates

Sign up for Insider News to receive breaking news updates from Breakthrough T1D.